|
1
|
Martin P and Leighl NB: Review of the use
of pretest probability for molecular testing in non-small cell lung
cancer and overview of new mutations that may affect clinical
practice. Ther Adv Med Oncol. 9:405–414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dong HX, Wang R, Jin XY, Zeng J and Pan J:
LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via
inhibiting hsa-mir-22-3p. J Cell Physiol. 233:4126–4136. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jan YH, Lai TC, Yang CJ, Huang MS and
Hsiao M: A co-expressed gene status of adenylate kinase 1/4 reveals
prognostic gene signature associated with prognosis and sensitivity
to EGFR targeted therapy in lung adenocarcinoma. Sci Rep.
9:123292019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bianconi D, Unseld M and Prager GW:
Integrins in the Spotlight of Cancer. Int J Mol Sci. 17:20372016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Slack-Davis JK and Parsons JT: Emerging
views of integrin signaling: Implications for prostate cancer. J
Cell Biochem. 91:41–46. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brakebusch C, Bouvard D, Stanchi F, Saki T
and Fassler R: Integrins in invasive growth. J Clin Invest.
109:999–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hynes RO: Integrins-Versatility,
modulation, and signaling in cell adhesion. Cell. 69:11–25. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang L, Dong Z, Zhang Y and Miao J: The
roles of integrin β4 in vascular endothelial cells. J Cell Physiol.
227:474–478. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma B, Zhang L, Zou YJ, He R, Wu Q, Han C
and Zhang B: Reciprocal regulation of integrin β4 and KLF4 promotes
gliomagenesis through maintaining cancer stem cell traits. J Exp
Clin Cancer Res. 38:232019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li XL, Liu L, Li DD, He YP, Guo LH, Sun
LP, Liu LN, Xu HX and Zhang XP: Integrin β 4 promotes cell invasion
and epithelial-mesenchymal transition through the modulation of
Slug expression in hepatocellular carcinoma. Sci Rep. 7:404642017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trusolino L, Bertotti A and Comoglio PM: A
signaling adapter function for alpha6beta4 integrin in the control
of HGF-dependent invasive growth. Cell. 107:643–654. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu P, Wang Y, Wu Y, Jia Z, Song Y and
Liang N: Expression and prognostic analyses of ITGA11, ITGB4 and
ITGB8 in human non-small cell lung cancer. Peerj. 7:e82992019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smyth GK, Michaud J and Scott HS: Use of
within-array replicate spots for assessing differential expression
in microarray experiments. Bioinformatics. 21:2067–2075. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang C, Liu J, Xiong B, Yonemura Y and
Yang X: Expression and prognosis analyses of forkhead box A (FOXA)
family in human lung cancer. Gene. 685:202–210. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qin Z, Xiang C, Zhong F, Liu Y, Dong Q, Li
K, Shi W, Ding C, Qin L and He F: Transketolase (TKT) activity and
nuclear localization promote hepatocellular carcinoma in a
metabolic and a non-metabolic manner. J Exp Clin Cancer Res.
38:1542019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tagliabue E, Ghirelli C, Squicciarini P,
Aiello P, Colnaghi MI and Menard S: Prognostic value of alpha 6
beta 4 integrin expression in breast carcinomas is affected by
laminin production from tumor cells. Clin Cancer Res. 4:407–410.
1998.PubMed/NCBI
|
|
23
|
Grossman HB, Lee C, Bromberg J and Liebert
M: Expression of the alpha6beta4 integrin provides prognostic
information in bladder cancer. Oncol Rep. 7:13–16. 2000.PubMed/NCBI
|
|
24
|
Gan L, Meng J, Xu M, Liu M, Qi Y, Tan C,
Wang Y, Zhang P, Weng W, Sheng W, et al: Extracellular matrix
protein 1 promotes cell metastasis and glucose metabolism by
inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric
cancer. Oncogene. 37:744–755. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Diaz LK, Cristofanilli M, Zhou X, Welch
KL, Smith TL, Yang Y, Sneige N, Sahin AA and Gilcrease MZ: beta4
integrin subunit gene expression correlates with tumor size and
nuclear grade in early breast cancer. Mod Pathol. 18:1165–1175.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang X, Wang J, Wang M, Xuan M, Han S, Li
C, Li M, Sun XF, Yu W and Zhao Z: ITGB4 as a novel serum diagnosis
biomarker and potential therapeutic target for colorectal cancer.
Cancer Med. 10:6823–6834. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meng X, Liu P, Wu Y, Liu X, Huang Y, Yu B,
Han J, Jin H and Tan X: Integrin beta 4 (ITGB4) and its
tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and
regulate the MEK1-ERK1/2 signaling pathway. Bosn J Basic Med Sci.
20:106–116. 2020.PubMed/NCBI
|
|
28
|
Wilkinson EJ, Woodworth AM, Parker M,
Phillips JL, Malley RC, Dickinson JL and Holloway AF: Epigenetic
regulation of the ITGB4 gene in prostate cancer. Exp Cell Res.
392:1120552020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ruan S, Lin M, Zhu Y, Lum L, Thakur A, Jin
R, Shao W, Zhang Y, Hu Y, Huang S, et al: Integrin β4-Targeted
cancer immunotherapies inhibit tumor growth and decrease
metastasis. Cancer Res. 80:771–783. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sena LA and Chandel NS: Physiological
roles of mitochondrial reactive oxygen species. Mol Cell.
48:158–167. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kubli DA and Gustafsson AB: Mitochondria
and mitophagy: The yin and yang of cell death control. Circ Res.
111:1208–1221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhuang Z, Zhou R, Xu X, Tian T, Liu Y, Liu
Y, Lian P, Wang J and Xu K: Clinical significance of integrin αvβ6
expression effects on gastric carcinoma invasiveness and
progression via cancer-associated fibroblasts. Med Oncol.
30:5802013. View Article : Google Scholar : PubMed/NCBI
|
